These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 21887901)

  • 41. Osteonecrosis of jaws after bisphosphonates: an internet resource on the web for dentist.
    Hon NC
    Singapore Dent J; 2007 Dec; 29(1):19-21. PubMed ID: 18472526
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management.
    Ruggiero SL; Fantasia J; Carlson E
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Oct; 102(4):433-41. PubMed ID: 16997108
    [No Abstract]   [Full Text] [Related]  

  • 43. Jaw osteonecrosis related to bisphosphonates: a new concern for dentistry.
    Geist RY; Geist JR; Aksu M
    J Mich Dent Assoc; 2005 Nov; 87(11):40-2. PubMed ID: 16372547
    [No Abstract]   [Full Text] [Related]  

  • 44. Bisphosphonate therapy and dental treatment.
    Phillips G
    J Mich Dent Assoc; 2009 Aug; 91(8):40, 42-5. PubMed ID: 19722373
    [No Abstract]   [Full Text] [Related]  

  • 45. Bisphosphonates, as a new cause of drug-induced jaw osteonecrosis: an update.
    Jimenez-Soriano Y; Bagan JV
    Med Oral Patol Oral Cir Bucal; 2005 Jul; 10 Suppl 2():E88-91. PubMed ID: 15995577
    [No Abstract]   [Full Text] [Related]  

  • 46. Complication related to bisphosphonate therapy: osteonecrosis of the jaw.
    Lee J
    J Infus Nurs; 2009; 32(6):330-5. PubMed ID: 19918142
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oral bisphosphonates and osteonecrosis of the jaw.
    Wynn RL
    Gen Dent; 2007; 55(1):8-10. PubMed ID: 17333956
    [No Abstract]   [Full Text] [Related]  

  • 48. Postmenopausal females and the link between oral bisphosphonates and osteonecrosis of the jaw: a clinical review.
    Haumschild MS; Haumschild RJ
    J Am Acad Nurse Pract; 2010 Oct; 22(10):534-9. PubMed ID: 21040087
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Osteonecrosis of the jaw correlated to bisphosphonate therapy in non-oncologic patients: clinicopathological features of 24 patients.
    Favia G; Pilolli GP; Maiorano E
    J Rheumatol; 2009 Dec; 36(12):2780-7. PubMed ID: 19884275
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Osteonecrosis and bisphosphonates in oral and maxillofacial surgery.
    Chaudhry AN; Ruggiero SL
    Oral Maxillofac Surg Clin North Am; 2007 May; 19(2):199-206, vi. PubMed ID: 18088878
    [TBL] [Abstract][Full Text] [Related]  

  • 51. I've heard that bisphosphonate medications used for osteoporosis can affect a person's jaw. Can you tell me more?
    Mayo Clin Womens Healthsource; 2008 Sep; 12(9):8. PubMed ID: 18667975
    [No Abstract]   [Full Text] [Related]  

  • 52. A review of bisphosphonate-associated osteonecrosis of the jaws and its management.
    Lam DK; Sándor GK; Holmes HI; Evans AW; Clokie CM
    J Can Dent Assoc; 2007 Jun; 73(5):417-22. PubMed ID: 17555652
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Osteonecrosis: what dentists need to know.
    Thoman RD
    Hawaii Dent J; 2006; 37(6):9-10, 12-3. PubMed ID: 17290948
    [No Abstract]   [Full Text] [Related]  

  • 54. Risk factors for bisphosphonate-related osteonecrosis of the jaws.
    Fleisher KE; Glickman RS
    J Oral Maxillofac Surg; 2011 Apr; 69(4):959; author reply 959-60. PubMed ID: 21440820
    [No Abstract]   [Full Text] [Related]  

  • 55. [Osteonecrosis of the jaw].
    Drozdzowska B
    Endokrynol Pol; 2011; 62 Suppl 3():4-9. PubMed ID: 22161980
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Osteonecrosis of the jaw after treatment with bisphosphonates: is irreversible, so the focus must be on prevention.
    Landis BN; Richter M; Dojcinovic I; Hugentobler M
    BMJ; 2006 Nov; 333(7576):982-3. PubMed ID: 17095762
    [No Abstract]   [Full Text] [Related]  

  • 57. Diabetes and the risk of osteonecrosis of the jaw.
    Favus MJ
    J Clin Endocrinol Metab; 2007 Mar; 92(3):817-8. PubMed ID: 17341579
    [No Abstract]   [Full Text] [Related]  

  • 58. Comments on "Osteonecrosis of the jaws in intravenous bisphosphonate use: proposal for a modification of the clinical classification".
    Woo SB; Mawardi H; Treister N
    Oral Oncol; 2009 Aug; 45(8):740. PubMed ID: 19038574
    [No Abstract]   [Full Text] [Related]  

  • 59. Bisphosphonate-associated osteonecrosis of the jaw.
    Khan A
    Can Fam Physician; 2008 Jul; 54(7):1019-21. PubMed ID: 18625828
    [No Abstract]   [Full Text] [Related]  

  • 60. Comments on ''Geranylgeraniol--a new potential therapeutic approach to bisphosphonate associated osteonecrosis of the jaw" by Ziebart T et al. (2011).
    Marcuzzi A; Zanin V; Crovella S; Pontillo A
    Oral Oncol; 2011 May; 47(5):436-7; author reply 438. PubMed ID: 21411362
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.